145 related articles for article (PubMed ID: 34046600)
1. Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting
Haranahalli K; Tong S; Kim S; Awwa M; Chen L; Knudson SE; Slayden RA; Singleton E; Russo R; Connell N; Ojima I
RSC Med Chem; 2021 Jan; 12(1):78-94. PubMed ID: 34046600
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.
Park B; Awasthi D; Chowdhury SR; Melief EH; Kumar K; Knudson SE; Slayden RA; Ojima I
Bioorg Med Chem; 2014 May; 22(9):2602-12. PubMed ID: 24726304
[TBL] [Abstract][Full Text] [Related]
3. SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.
Awasthi D; Kumar K; Knudson SE; Slayden RA; Ojima I
J Med Chem; 2013 Dec; 56(23):9756-70. PubMed ID: 24266862
[TBL] [Abstract][Full Text] [Related]
4. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
[TBL] [Abstract][Full Text] [Related]
5. Computational studies of the properties and activities of selected trisubstituted benzimidazoles as potential antitubercular drugs inhibiting MTB-FtsZ polymerization.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
J Biomol Struct Dyn; 2022 Mar; 40(4):1558-1570. PubMed ID: 33021149
[TBL] [Abstract][Full Text] [Related]
6. Efficient Synthesis of Amine-Linked 2,4,6-Trisubstituted Pyrimidines as a New Class of Bacterial FtsZ Inhibitors.
Chan KF; Sun N; Yan SC; Wong ILK; Lui HK; Cheung KC; Yuan J; Chan FY; Zheng Z; Chan EWC; Chen S; Leung YC; Chan TH; Wong KY
ACS Omega; 2017 Oct; 2(10):7281-7292. PubMed ID: 30023544
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of fascaplysin derivatives as inhibitors of FtsZ with potent antibacterial activity and mechanistic study.
Qiu H; Zhao X; Jiang Y; Liang W; Wang W; Jiang X; Jiang M; Wang X; Cui W; Li Y; Tang K; Zhang T; Zhao L; Liang H
Eur J Med Chem; 2023 Jun; 254():115348. PubMed ID: 37060755
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of biphenyl-benzamides as potent FtsZ inhibitors.
Deng J; Zhang T; Li B; Xu M; Wang Y
Eur J Med Chem; 2022 Sep; 239():114553. PubMed ID: 35763867
[TBL] [Abstract][Full Text] [Related]
9. Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ.
Ojima I; Awasthi D; Wei L; Haranahalli K
J Fluor Chem; 2017 Apr; 196():44-56. PubMed ID: 28555087
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Antimycobacterial Activity of 2,5-Disubstituted and 1,2,5-Trisubstituted Benzimidazoles.
Jiménez-Juárez R; Cruz-Chávez W; de Jesús-Ramírez N; Castro-Ramírez GI; Uribe-González I; Martínez-Mejía G; Ruiz-Nicolás R; Aguirre-Alvarado C; Castrejón-Jiménez NS; García-Pérez BE
Front Chem; 2020; 8():433. PubMed ID: 32656177
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study.
Zhong DX; She MT; Guo XC; Zheng BX; Huang XH; Zhang YH; Ser HL; Wong WL; Sun N; Lu YJ
Eur J Med Chem; 2022 Jun; 236():114360. PubMed ID: 35421657
[TBL] [Abstract][Full Text] [Related]
13. Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains.
Li Z; Bai X; Deng Q; Zhang G; Zhou L; Liu Y; Wang J; Wang Y
Bioorg Med Chem; 2017 Jan; 25(1):213-220. PubMed ID: 27810439
[TBL] [Abstract][Full Text] [Related]
14. A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
PLoS One; 2014; 9(4):e93953. PubMed ID: 24736743
[TBL] [Abstract][Full Text] [Related]
15. FtsZ inhibitors as a new genera of antibacterial agents.
Tripathy S; Sahu SK
Bioorg Chem; 2019 Oct; 91():103169. PubMed ID: 31398602
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study.
Mitra K; Chadha A; Doble M
Eur J Pharm Sci; 2019 Jul; 135():103-112. PubMed ID: 31034983
[TBL] [Abstract][Full Text] [Related]
17. SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.
Dokla EME; Abutaleb NS; Milik SN; Kandil EAEA; Qassem OM; Elgammal Y; Nasr M; McPhillie MJ; Abouzid KAM; Seleem MN; Imming P; Adel M
Eur J Med Chem; 2023 Feb; 247():115040. PubMed ID: 36584632
[TBL] [Abstract][Full Text] [Related]
18. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
[TBL] [Abstract][Full Text] [Related]
19. An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors.
Khadkikar P; Goud NS; Mohammed A; Ramamoorthy G; Ananthathatmula R; Doble M; Rizvi A; Banerjee S; Ravi A; Alvala M
Chem Biol Drug Des; 2018 Dec; 92(6):1933-1939. PubMed ID: 30003661
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
Barot KP; Jain SV; Gupta N; Kremer L; Singh S; Takale VB; Joshi K; Ghate MD
Eur J Med Chem; 2014 Aug; 83():245-55. PubMed ID: 24972340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
